Cordatus Wealth Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Buy |
1,063
+4
| +0.4% | +$1.15K | 0.08% | 140 |
|
|
2025
Q1 | $326K | Buy |
1,059
+28
| +3% | +$8.62K | 0.09% | 122 |
|
|
2024
Q4 | $364K | Sell |
1,031
-1
| -0.1% | -$353 | 0.1% | 116 |
|
|
2024
Q3 | $370K | Sell |
1,032
-4
| -0.4% | -$1.43K | 0.13% | 97 |
|
|
2024
Q2 | $330K | Sell |
1,036
-5
| -0.5% | -$1.59K | 0.12% | 103 |
|
|
2024
Q1 | $239K | Sell |
1,041
-2
| -0.2% | -$459 | 0.17% | 53 |
|
|
2023
Q4 | $229K | Sell |
1,043
-12
| -1% | -$2.64K | 0.19% | 52 |
|
|
2023
Q3 | $238K | Sell |
1,055
-20
| -2% | -$4.51K | 0.22% | 54 |
|
|
2023
Q2 | $237K | Buy |
+1,075
| New | +$237K | 0.09% | 140 |
|